Corcept Therapeutics
CORT
CORT
416 hedge funds and large institutions have $9.14B invested in Corcept Therapeutics in 2025 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 127 increasing their positions, 141 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 141
2.34% less ownership
Funds ownership: 80.38% → 78.04% (-2.3%)
42% less call options, than puts
Call options by funds: $193M | Put options by funds: $335M
Holders
416
Holding in Top 10
16
Calls
$193M
Puts
$335M
Top Buyers
| 1 | +$68.1M | |
| 2 | +$61.7M | |
| 3 | +$39M | |
| 4 |
Morgan Stanley
New York
|
+$31.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.7M |
Top Sellers
| 1 | -$113M | |
| 2 | -$40.8M | |
| 3 | -$35.9M | |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
-$33.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$33.1M |
